Temperature-controlled radiofrequency neurolysis of the posterior nasal nerve improved the symptom burden and quality of life of patients with chronic rhinitis through 24 months, according to a study published in Allergy & Rhinology.
“This study was an extension of an earlier study exploring the impact of RhinAer on rhinitis symptom burden through 12 months,” Dale R. Ehmer Jr., MD, FACS, of Ear, Nose & Throat Associates of Texas in McKinney, Texas, told Healio.
The RhinAer System (Aerin Medical Inc.) generates and sends 4 W of 60°C temperature-controlled bipolar